Bhim Sen Singhal
Bhim Sen Singhal publishes mostly in Pathology and Forensic Medicine, Neurology and Rheumatology, on topics such as Multiple Sclerosis Research Studies, Systemic Lupus Erythematosus Research and Peripheral Neuropathies and Disorders.
- World rank
- #996,150 of 7,710,434 ranked researchers
- Rank in India
- #13,924 of 280,097
- Works
- 55
- Citations
- 1.8k
- Citations per work
- 33.1
What does Bhim Sen Singhal research?
Bhim Sen Singhal's work is mostly in Medicine (60%), Biochemistry, Genetics and Molecular Biology (8%), Neuroscience (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences3359.7%
- Medicine3359.7%
- Everything else1322.8%
- Life Sciences1017.5%
- 1Pathology and Forensic Medicine28% of their works
- 2Neurology19% of their works
- 3Rheumatology13% of their works
- 4Molecular Biology8% of their works
- 5Neurology7% of their works
- 6Immunology3% of their works
Research topics
- Multiple Sclerosis Research Studies
- Systemic Lupus Erythematosus Research
- Peripheral Neuropathies and Disorders
- Rheumatoid Arthritis Research and Therapies
- RNA regulation and disease
- Neuroinflammation and Neurodegeneration Mechanisms
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
Which keywords describe Bhim Sen Singhal's research?
The keywords of their largest research topics: Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Autoantibodies, Neurological Disorders, Cytokines, Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
- Subthalamic Nucleus
- Microglia
- Deep Brain Stimulation
- ADAR Deaminases
- Parkinson's Disease
- Inflammation
- Guillain-Barré Syndrome
- Systemic Lupus Erythematosus
- Cytokines
- Autoantibodies
- Multiple Sclerosis
- Diagnostic Criteria
- Neuromyelitis Optica
- Neurological Disorders
- Antiphospholipid Syndrome
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Innate Immunity
- Neurodegeneration
- Rheumatoid Arthritis
- RNA Editing
- Dopaminergic Neurons
- Neuroinflammation
- a-Synuclein
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Diagnostic Criteria402 topics
- Multiple Sclerosis361 topic
- Neuromyelitis Optica361 topic
- Autoantibodies192 topics
- Neurological Disorders183 topics
- Cytokines122 topics
- Antiphospholipid Syndrome111 topic
- Systemic Lupus Erythematosus111 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy91 topic
- Guillain-Barré Syndrome91 topic
- Innate Immunity92 topics
- Inflammation81 topic
- Neurodegeneration82 topics
- Parkinson's Disease82 topics
- Rheumatoid Arthritis81 topic
- ADAR Deaminases51 topic
- RNA Editing51 topic
- Deep Brain Stimulation41 topic
- Dopaminergic Neurons41 topic
- Microglia41 topic
- Neuroinflammation41 topic
- Subthalamic Nucleus41 topic
- a-Synuclein41 topic
Where does Bhim Sen Singhal work?
Bhim Sen Singhal's main affiliation in the publication record is Bombay Hospital, India.
How many publications and citations does Bhim Sen Singhal have?
OpenAlex counts 55 works and 1,822 citations for Bhim Sen Singhal, an h-index of 25, ranking #996,150 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Bhim Sen Singhal. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.